Anpario plc announces that on 2 November 2020 the Company has granted further options under The Anpario Share Option Scheme 2013 (the 'SAYE Scheme ') which is approved by H.M. Revenue and Customs.
Certain employees (the 'SAYE Scheme Participants') of the Group have chosen to participate in the SAYE Scheme, pursuant to which, subject to certain customary conditions being satisfied, they will be able to subscribe for, in aggregate, up to 91,504 ordinary shares in the capital of the Company ('Shares'). The executive directors of the Company, Richard Edwards and Karen Prior, are both SAYE Scheme Participants and, subject to the same conditions being satisfied, they will each be able to subscribe for up to 5,577 Shares.
The entitlements to subscribe arise following the end of the three year period to 31 January 2024. The exercise price per Share is set at 322.72 pence and the SAYE Scheme Participants may opt to withdraw from the SAYE Scheme, recovering paid-in funds, prior to that time.
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Richard Edwards
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Anpario plc
b)
LEI
213800BZHUIUCH3MCC06
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Purchase of ordinary shares of 23 pence each in the Company ('Ordinary Shares')
ISIN GB00B3NWT178
b)
Nature of the transaction
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
322.72p
5,577
d)
Aggregated information
Price(s)
Volume(s)
322.72p
5,577
e)
Date of the transaction
2020-11-02
f)
Place of the transaction
London Stock Exchange (XLON), AIM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Karen Prior
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Anpario plc
b)
LEI
213800BZHUIUCH3MCC06
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Purchase of ordinary shares of 23 pence each in the Company ('Ordinary Shares')
ISIN GB00B3NWT178
b)
Nature of the transaction
Grant of options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
322.72p
5,577
d)
Aggregated information
Price(s)
Volume(s)
322.72p
5,577
e)
Date of the transaction
2020-11-02
f)
Place of the transaction
London Stock Exchange (XLON), AIM
Enquiries:
Anpario plc
Richard Edwards, Chief Executive Officer +44 (0)7776 417129
Karen Prior, Group Finance Director +44 (0)1909 537 380
Peel Hunt
Adrian Trimmings, Andrew Clark, Will Bell +44 (0) 207 418 8900
Back to RNS Announcements
Attachments
Original document
Permalink
Disclaimer
Anpario plc published this content on 05 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 November 2020 17:00:04 UTC
Anpario plc is a United Kingdom-based independent manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity. The Company's main focus is understanding animals' intestinal health and nutrition. Its feed addictive solutions include poultry, ruminant, swine, aqua and feed mill. Its product categories include health & performance, toxin management, feed quality, and hygiene & insect control. Its health & performance products include Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range. Its toxin management products include Anpro Range and Anpro Advance. Its feed quality products include pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range. Its hygiene & insect control products include Mitex, Clean & Dry and Credence. Its technologies are sold in over 80 countries through established sales and distribution networks, which includes a number of wholly owned subsidiaries.
ANPARIO PLC 
